Data search
Results for MligTC455_15022
| Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
|---|---|---|---|---|---|---|
| MligTC455_15022 | 16 | 0.33 | Mlig455_040949 | Neo: - Age: - |
PRKAR2B | Mlig455_040949 {REF} {Length: 1526} {Pfam: Cyclic nucleotide-binding domain [PF00027.31, score=128.5]} {Human: ENSG00000005249, PRKAR2B, protein kinase cAMP-dependent type II regulatory subunit beta, [Score=191, Expect=3e-57]; ENSG00000284096, PRKAR2B, protein kinase cAMP-dependent type II regulatory subunit beta, [Score=191, Expect=3e-57]; ENSG00000114302, PRKAR2A, protein kinase cAMP-dependent type II regulatory subunit alpha, [Score=190, Expect=5e-57]} {Mouse: ENSMUSG00000002997, Prkar2b, protein kinase, cAMP dependent regulatory, type II beta, [Score=189, Expect=1e-56]; ENSMUSG00000032601, Prkar2a, protein kinase, cAMP dependent regulatory, type II alpha, [Score=188, Expect=2e-56]} {Dmel: FBgn0022382, Pka-R2, Protein kinase, cAMP-dependent, regulatory subunit type 2, [Score=217, Expect=5e-68]} {Celegans: WBGene00002190, kin-2, cAMP-dependent protein kinase regulatory subunit, [Score=130, Expect=3e-35]} {Smed: dd_Smed_v6_2902_0_1, dd_Smed_v6_2902_0_1, [Score=187, Expect=8e-57]} {RNA1310_91044} {RNA815_60658} |
Cumulative graph for MligTC455_15022
Region-enriched expression
| Region | logFC | logCPM | Pvalue | FDR | Specificity |
|---|---|---|---|---|---|
| RegionR1 | -1.732 | 0.737 | 0.99949 | 1.00000 | |
| RegionR2 | 2.624 | 0.737 | 0.91828 | 1.00000 | |
| RegionR3 | 0.58 | 0.737 | 0.94216 | 1.00000 | |
| RegionR4 | -0.425 | 0.737 | 0.99919 | 1.00000 | |
| RegionR5 | 0.345 | 0.737 | 0.49521 | 0.85856 | |
| RegionR6 | -1.745 | 0.737 | 0.99917 | 1.00000 | |
| RegionR7 | 1.705 | 0.737 | 0.42189 | 1.00000 | |
| RegionR8 | -1.353 | 0.737 | 1.00000 | 1.00000 |
Regeneration-enriched expression
| Region | logFC | logCPM | PValue | FDR | Specificity |
|---|---|---|---|---|---|
| RegenerationR1 | -0.935 | 0.737 | 0.99976 | 1.00000 | |
| RegenerationR2 | -1.935 | 0.737 | 0.36438 | 0.79132 | |
| RegenerationR3 | -1.569 | 0.737 | 0.40173 | 0.80348 | |
| RegenerationR4 | -0.618 | 0.737 | 0.90012 | 1.00000 | |
| RegenerationR5 | -2.419 | 0.737 | 0.16771 | 0.59435 | |
| RegenerationR6 | -1.214 | 0.737 | 0.99981 | 1.00000 | |
| RegenerationBL | -2.232 | 0.737 | 0.99937 | 1.00000 | |
| RegenerationTP | -2.541 | 0.737 | 0.99951 | 1.00000 |
Genes with expression patterns similar to MligTC455_15022
| Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. | MligTC455_15022 | 16 | 0.33 | Mlig455_040949 | Neo: - Age: - |
PRKAR2B | 3 | 1.000 | - | 1.000 | - | 1.000 | - | Mlig455_040949 {REF} {Length: 1526} {Pfam: Cyclic nucleotide-binding domain [PF00027.31, score=128.5]} {Human: ENSG00000005249, PRKAR2B, protein kinase cAMP-dependent type II regulatory subunit beta, [Score=191, Expect=3e-57]; ENSG00000284096, PRKAR2B, protein kinase cAMP-dependent type II regulatory subunit beta, [Score=191, Expect=3e-57]; ENSG00000114302, PRKAR2A, protein kinase cAMP-dependent type II regulatory subunit alpha, [Score=190, Expect=5e-57]} {Mouse: ENSMUSG00000002997, Prkar2b, protein kinase, cAMP dependent regulatory, type II beta, [Score=189, Expect=1e-56]; ENSMUSG00000032601, Prkar2a, protein kinase, cAMP dependent regulatory, type II alpha, [Score=188, Expect=2e-56]} {Dmel: FBgn0022382, Pka-R2, Protein kinase, cAMP-dependent, regulatory subunit type 2, [Score=217, Expect=5e-68]} {Celegans: WBGene00002190, kin-2, cAMP-dependent protein kinase regulatory subunit, [Score=130, Expect=3e-35]} {Smed: dd_Smed_v6_2902_0_1, dd_Smed_v6_2902_0_1, [Score=187, Expect=8e-57]} {RNA1310_91044} {RNA815_60658} |
| 2. | MligTC455_47590 | 22 | 0.46 | Mlig455_017675, Mlig455_053765 | Neo: - Age: - |
LRRC74A | 2.767 | 0.894 | - | 0.952 | - | 0.921 | - | Mlig455_017675 {REF} {Length: 3797} {Pfam: Leucine Rich repeat [PF13516.8, score=47.9]; EF-hand domain pair [PF13499.8, score=29.1]; EF-hand domain [PF13405.8, score=28.8]; EF hand [PF00036.34, score=28.6]; EF-hand domain pair [PF13833.8, score=18.6]} {Human: ENSG00000100565, LRRC74A, leucine rich repeat containing 74A, [Score=143, Expect=3e-36]} {Mouse: ENSMUSG00000059114, Lrrc74a, leucine rich repeat containing 74A, [Score=142, Expect=5e-36]} {Celegans: WBGene00000554, cnb-1, Protein phosphatase 2B regulatory subunit cnb-1, [Score=50.4, Expect=5e-07]} {Smed: dd_Smed_v6_14506_0_1, dd_Smed_v6_14506_0_1, [Score=169, Expect=4e-45]} {RNA1310_50089} Mlig455_053765 {REF} {Length: 3797} {Pfam: Leucine Rich repeat [PF13516.8, score=47.9]; EF-hand domain pair [PF13499.8, score=29.1]; EF-hand domain [PF13405.8, score=28.8]; EF hand [PF00036.34, score=28.6]; EF-hand domain pair [PF13833.8, score=18.6]} {Human: ENSG00000100565, LRRC74A, leucine rich repeat containing 74A, [Score=143, Expect=3e-36]} {Mouse: ENSMUSG00000059114, Lrrc74a, leucine rich repeat containing 74A, [Score=142, Expect=5e-36]} {Celegans: WBGene00000554, cnb-1, Protein phosphatase 2B regulatory subunit cnb-1, [Score=50.4, Expect=5e-07]} {Smed: dd_Smed_v6_14506_0_1, dd_Smed_v6_14506_0_1, [Score=169, Expect=4e-45]} {RNA1310_50089} |
| 3. | MligTC455_51557 | 57 | 1.19 | Mlig455_038195 | Neo: - Age: Down-Up-Up |
ISL1 | 2.738 | 0.938 | - | 0.846 | - | 0.954 | - | Mlig455_038195 {REF} {Length: 2149} {Pfam: LIM domain [PF00412.24, score=91.4]; Homeodomain [PF00046.31, score=55.3]; Homeobox KN domain [PF05920.13, score=23.4]} {Human: ENSG00000016082, ISL1, ISL LIM homeobox 1, [Score=180, Expect=9e-52]; ENSG00000159556, ISL2, ISL LIM homeobox 2, [Score=173, Expect=3e-49]} {Mouse: ENSMUSG00000042258, Isl1, ISL1 transcription factor, LIM/homeodomain, [Score=180, Expect=6e-52]; ENSMUSG00000032318, Isl2, insulin related protein 2 (islet 2), [Score=175, Expect=4e-50]} {Dmel: FBgn0003896, tup, tailup, [Score=151, Expect=3e-40]} {Celegans: WBGene00002989, lim-7, CeLIM-7; LIM domain family, [Score=142, Expect=2e-37]} {Smed: dd_Smed_v6_8820_0_1, dd_Smed_v6_8820_0_1, [Score=303, Expect=1e-97]} {RNA1310_54855} {RNA815_46288} |
| 4. | MligTC455_53594 | 55 | 1.15 | Mlig455_028296, Mlig455_069567 | Neo: - Age: Down-Up-Down |
SLC24A2 | 2.69 | 0.986 | - | 0.877 | - | 0.827 | - | Mlig455_028296 {REF} {Length: 4685} {Pfam: Sodium/calcium exchanger protein [PF01699.26, score=158.5]} {Human: ENSG00000155886, SLC24A2, solute carrier family 24 member 2, [Score=453, Expect=4e-151]} {Mouse: ENSMUSG00000037996, Slc24a2, solute carrier family 24 (sodium/potassium/calcium exchanger), member 2, [Score=453, Expect=9e-151]} {Dmel: FBgn0028704, Nckx30C, [Score=460, Expect=2e-151]} {Celegans: WBGene00003569, ncx-4, Na/Ca eXchangers, [Score=222, Expect=5e-64]} {Smed: dd_Smed_v6_5868_0_4, dd_Smed_v6_5868_0_4, [Score=186, Expect=2e-51]} {RNA1509_26587} {RNA1310_76563} {RNA815_21902.1} Mlig455_069567 {REF} {Length: 4230} {Pfam: Sodium/calcium exchanger protein [PF01699.26, score=186.7]} {Human: ENSG00000155886, SLC24A2, solute carrier family 24 member 2, [RH, Score=496, Expect=1e-167]} {Mouse: ENSMUSG00000037996, Slc24a2, solute carrier family 24 (sodium/potassium/calcium exchanger), member 2, [RH, Score=501, Expect=4e-169]} {Dmel: FBgn0028704, Nckx30C, [RH, Score=501, Expect=3e-167]} {Celegans: WBGene00003569, ncx-4, Na/Ca eXchangers, [Score=226, Expect=4e-65]} {Smed: dd_Smed_v6_5868_0_4, dd_Smed_v6_5868_0_4, [Score=186, Expect=2e-51]} {RNA1509_26587} {RNA1310_76563} {RNA815_21902.1} |
| 5. | MligTC455_45898 | 87 | 1.82 | Mlig455_058293 | Neo: - Age: - |
CUX2 | 2.659 | 0.914 | - | 0.789 | - | 0.956 | - | Mlig455_058293 {REF} {Length: 4328} {Pfam: CUT domain [PF02376.17, score=197.2]; Homeodomain [PF00046.31, score=53.8]; Homeobox KN domain [PF05920.13, score=29.1]} {Human: ENSG00000111249, CUX2, cut like homeobox 2, [Score=144, Expect=3e-34]} {Mouse: ENSMUSG00000042589, Cux2, cut-like homeobox 2, [Score=148, Expect=1e-35]} {Dmel: FBgn0004198, ct, cut, [Score=123, Expect=4e-28]} {Celegans: WBGene00000464, ceh-44, Homeobox protein cut-like ceh-44, [RH, Score=142, Expect=4e-34]} {Smed: dd_Smed_v6_13843_0_1, dd_Smed_v6_13843_0_1, [Score=125, Expect=6e-29]} {RNA1310_11859} {RNA815_40841} |
| 6. | MligTC455_13421 | 86 | 1.79 | Mlig455_036504, Mlig455_069144 | Neo: - Age: - |
SYT17 | 2.656 | 0.982 | - | 0.716 | - | 0.958 | - | Mlig455_036504 {REF} {Length: 2390} {Pfam: C2 domain [PF00168.32, score=84.3]} {Human: ENSG00000103528, SYT17, synaptotagmin 17, [Score=137, Expect=5e-35]} {Mouse: ENSMUSG00000058420, Syt17, synaptotagmin XVII, [Score=137, Expect=6e-35]} {Dmel: FBgn0028400, Syt4, Synaptotagmin 4, [Score=101, Expect=1e-22]} {Celegans: WBGene00004922, snt-2, Synaptotagmin 2, [Score=105, Expect=2e-24]} {Smed: dd_Smed_v6_19213_0_1, dd_Smed_v6_19213_0_1, [RH, Score=124, Expect=2e-30]} {RNA1310_17303} {RNA815_33031} Mlig455_069144 {REF} {Length: 1355} {Pfam: C2 domain [PF00168.32, score=84.3]} {Human: ENSG00000103528, SYT17, synaptotagmin 17, [Score=137, Expect=5e-35]} {Mouse: ENSMUSG00000058420, Syt17, synaptotagmin XVII, [Score=137, Expect=6e-35]} {Dmel: FBgn0028400, Syt4, Synaptotagmin 4, [Score=101, Expect=1e-22]} {Celegans: WBGene00004922, snt-2, Synaptotagmin 2, [Score=105, Expect=2e-24]} {Smed: dd_Smed_v6_19213_0_1, dd_Smed_v6_19213_0_1, [RH, Score=124, Expect=2e-30]} {RNA1310_17303} {RNA815_33031} |
| 7. | MligTC455_24064 | 359 | 7.48 | Mlig455_048183 | Neo: - Age: - |
SNAP25 | 2.644 | 0.957 | - | 0.716 | - | 0.971 | - | Mlig455_048183 {REF} {Length: 1315} {Pfam: SNAP-25 family [PF00835.21, score=41.5]} {Human: ENSG00000132639, SNAP25, synaptosome associated protein 25, [Score=219, Expect=7e-72]} {Mouse: ENSMUSG00000027273, Snap25, synaptosomal-associated protein 25, [Score=219, Expect=5e-72]} {Dmel: FBgn0266720, Snap24, Synaptosomal-associated protein 24kDa, [RH, Score=228, Expect=1e-75]} {Celegans: WBGene00004364, ric-4, Synaptosomal-associated protein, [RH, Score=257, Expect=2e-87]} {Smed: dd_Smed_v6_3977_0_1, dd_Smed_v6_3977_0_1, [RH, Score=282, Expect=2e-97]} {RNA1509_8624} {RNA1310_24253} {RNA815_10439} |
| 8. | MligTC455_13403 | 157 | 3.27 | Mlig455_058321 | Neo: - Age: Down-Up-Down Region-enriched R2: 2.878/0.03174 |
LARP1 | 2.5 | 0.791 | - | 0.752 | - | 0.957 | - | Mlig455_058321 {REF} {Length: 2328} {Human: ENSG00000155506, LARP1, La ribonucleoprotein domain family member 1, [Score=178, Expect=6e-52]} {Mouse: ENSMUSG00000037331, Larp1, La ribonucleoprotein domain family, member 1, [Score=178, Expect=5e-52]; ENSMUSG00000025762, Larp1b, La ribonucleoprotein domain family, member 1B, [Score=171, Expect=9e-54]} {Dmel: FBgn0261618, larp, La related protein, [Score=172, Expect=4e-50]} {Celegans: WBGene00020097, larp-1, La-related protein 1, [Score=136, Expect=2e-37]} {Smed: dd_Smed_v6_2667_0_1, dd_Smed_v6_2667_0_1, [Score=170, Expect=2e-49]} {RNA1509_29509} {RNA1310_3597.2, RNA1509_29509} {RNA1509_29509, RNA815_2607} |
| 9. | MligTC455_47601 | 126 | 2.62 | Mlig455_056477 | Neo: - Age: Up-Down-Up |
NRXN1 | 2.463 | 0.758 | - | 0.734 | - | 0.971 | - | Mlig455_056477 {REF} {Length: 3481} {Pfam: Laminin G domain [PF02210.26, score=58.3]; Laminin G domain [PF00054.25, score=43.2]; Syndecan domain [PF01034.22, score=27.4]} {Human: ENSG00000179915, NRXN1, neurexin 1, [Score=142, Expect=4e-35]} {Mouse: ENSMUSG00000024109, Nrxn1, neurexin I, [Score=142, Expect=1e-35]} {Dmel: FBgn0038975, Nrx-1, Neurexin 1, [Score=102, Expect=2e-22]} {Smed: dd_Smed_v6_13697_0_1, dd_Smed_v6_13697_0_1, [Score=142, Expect=8e-36]} {RNA1509_55888} {RNA1310_37025, RNA1509_55888} {RNA1509_55888, RNA815_22404} |
| 10. | MligTC455_41430 | 65 | 1.35 | Mlig455_070915 | Neo: - Age: - |
BHLHE22 | 1.982 | 0.988 | - | - | - | 0.994 | - | Mlig455_070915 {REF} {Length: 1052} {Pfam: Helix-loop-helix DNA-binding domain [PF00010.28, score=58.4]} {Human: ENSG00000180828, BHLHE22, basic helix-loop-helix family member e22, [RH, Score=135, Expect=4e-37]} {Mouse: ENSMUSG00000025128, Bhlhe22, basic helix-loop-helix family, member e22, [RH, Score=133, Expect=8e-37]; ENSMUSG00000045493, Bhlhe23, basic helix-loop-helix family, member e23, [RH, Score=129, Expect=1e-36]} {Dmel: FBgn0032651, Oli, Olig family, [RH, Score=135, Expect=4e-39]} {Celegans: WBGene00001961, hlh-17, Helix Loop Helix, [RH, Score=103, Expect=2e-28]} {Smed: dd_Smed_v6_12722_0_1, dd_Smed_v6_12722_0_1, [RH, Score=129, Expect=2e-37]} {RNA1310_107478} |
| 11. | MligTC455_43454 | 36 | 0.74 | Mlig455_043999 | Neo: - Age: - |
1.964 | 0.981 | - | - | - | 0.983 | - | Mlig455_043999 {REF} {Length: 2456} {Dmel: FBgn0259222, CG42322, [RH, Score=101, Expect=3e-22]} {Smed: dd_Smed_v6_18554_0_1, dd_Smed_v6_18554_0_1, [Score=82.4, Expect=1e-17]} {RNA1310_20749} {RNA815_38231} | |
| 12. | MligTC455_25920 | 378 | 7.87 | Mlig455_006540 | Neo: - |
1.955 | 0.976 | - | - | - | 0.979 | - | Mlig455_006540 {REF} {Length: 1697} {RNA1509_12380} {RNA1310_42539} {RNA815_19957} | |
| 13. | MligTC455_27799 | 414 | 8.62 | Mlig455_004285, Mlig455_004370 | Neo: - Age: Down-Up-Down Region-specific R2: 3.850 Region-enriched R2: 5.047/0.00000 |
1.952 | 0.962 | - | - | - | 0.990 | - | Mlig455_004285 {REF} {Length: 650} {RNA1509_56105} {RNA1310_32410} {RNA815_17871.1} Mlig455_004370 {REF} {Length: 1653} {RNA1509_56105} {RNA1310_32410} {RNA815_17871.1} |
|
| 14. | MligTC455_43390 | 28 | 0.59 | Mlig455_064273 | Neo: - Age: Down-Up-Down |
PRKAR2A | 1.946 | 0.988 | - | - | - | 0.958 | - | Mlig455_064273 {REF} {Length: 2394} {Pfam: Cyclic nucleotide-binding domain [PF00027.31, score=122.5]; Regulatory subunit of type II PKA R-subunit [PF02197.19, score=40.5]} {Human: ENSG00000114302, PRKAR2A, protein kinase cAMP-dependent type II regulatory subunit alpha, [Score=305, Expect=2e-100]; ENSG00000005249, PRKAR2B, protein kinase cAMP-dependent type II regulatory subunit beta, [Score=296, Expect=8e-97]; ENSG00000284096, PRKAR2B, protein kinase cAMP-dependent type II regulatory subunit beta, [Score=296, Expect=8e-97]} {Mouse: ENSMUSG00000032601, Prkar2a, protein kinase, cAMP dependent regulatory, type II alpha, [Score=314, Expect=6e-104]} {Dmel: FBgn0022382, Pka-R2, Protein kinase, cAMP-dependent, regulatory subunit type 2, [Score=335, Expect=1e-112]} {Celegans: WBGene00002190, kin-2, cAMP-dependent protein kinase regulatory subunit, [Score=219, Expect=2e-68]} {Smed: dd_Smed_v6_4188_0_1, dd_Smed_v6_4188_0_1, [Score=335, Expect=5e-113]} {RNA1509_34470} {RNA1310_27777} {RNA815_5628} |
| 15. | MligTC455_40199 | 64 | 1.33 | Mlig455_026444, Mlig455_026477 | Neo: - Age: - |
ASIC4 | 1.939 | 0.945 | - | - | - | 0.994 | - | Mlig455_026444 {REF} {Length: 2570} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=204.0]} {Human: ENSG00000072182, ASIC4, acid sensing ion channel subunit family member 4, [Score=57.4, Expect=7e-08]} {Mouse: ENSMUSG00000033007, Asic4, acid-sensing (proton-gated) ion channel family member 4, [Score=53.9, Expect=5e-07]; ENSMUSG00000038276, Asic3, acid-sensing (proton-gated) ion channel 3, [Score=52.4, Expect=1e-06]} {Celegans: WBGene00003174, mec-10, Degenerin mec-10, [Score=69.7, Expect=5e-12]} {Smed: dd_Smed_v6_12878_0_1, dd_Smed_v6_12878_0_1, [Score=119, Expect=6e-28]} {RNA1310_21223} {RNA815_27174} Mlig455_026477 {REF} {Length: 2402} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=160.5]} {Human: ENSG00000072182, ASIC4, acid sensing ion channel subunit family member 4, [Score=57.0, Expect=8e-08]} {Mouse: ENSMUSG00000033007, Asic4, acid-sensing (proton-gated) ion channel family member 4, [Score=53.9, Expect=5e-07]} {Celegans: WBGene00003174, mec-10, Degenerin mec-10, [Score=69.3, Expect=5e-12]} {Smed: dd_Smed_v6_12878_0_1, dd_Smed_v6_12878_0_1, [Score=93.6, Expect=9e-20]} {RNA1310_21223} {RNA815_27174} |
| 16. | MligTC455_48604 | 173 | 3.6 | Mlig455_031074 | Neo: - |
1.937 | 0.985 | - | - | - | 0.952 | - | Mlig455_031074 {REF} {Length: 652} {RNA1310_66509} | |
| 17. | MligTC455_19249 | 90 | 1.86 | Mlig455_054092 | Neo: - Age: Down-Up-Up Region-enriched R2: 7.298/0.00139 |
1.934 | 0.953 | - | - | - | 0.981 | - | Mlig455_054092 {REF} {Length: 667} {TRANSSPLICED} {RNA1509_57448} {RNA1310_51394, RNA1509_57448} {RNA1509_57448, RNA815_26076} | |
| 18. | MligTC455_16209 | 72 | 1.51 | Mlig455_020329 | Neo: - Age: - Region-enriched R2: 5.444/0.00658 |
1.93 | 0.953 | - | - | - | 0.977 | - | Mlig455_020329 {REF} {Length: 2483} {Pfam: TIR domain [PF13676.8, score=38.4]; TIR domain [PF01582.22, score=29.5]; Domain of unknown function (DUF4481) [PF14800.8, score=20.4]} {Dmel: FBgn0032095, Toll-4, [RH, Score=53.1, Expect=7e-07]} {Smed: dd_Smed_v6_14454_0_1, dd_Smed_v6_14454_0_1, [RH, Score=270, Expect=2e-82]} {RNA1310_32445} {RNA815_27719} | |
| 19. | MligTC455_13734 | 19 | 0.4 | Mlig455_066088 | Neo: - Age: Down-Up-Down |
1.927 | 0.980 | - | - | - | 0.947 | - | Mlig455_066088 {REF} {Length: 1207} {RNA1310_47485} {RNA815_44269} | |
| 20. | MligTC455_17178 | 54 | 1.12 | Mlig455_067758 | Neo: - Age: - Region-enriched R2: 7.471/0.00007 |
1.919 | 0.987 | - | - | - | 0.932 | - | Mlig455_067758 {REF} {Length: 2301} {RNA1509_44702} {RNA1310_14743} {RNA815_20669.1} | |
| 21. | MligTC455_31172 | 195 | 4.06 | Mlig455_028354 | Neo: - Age: - Region-enriched R5: 4.005/0.04475 |
1.919 | 0.926 | - | - | - | 0.993 | - | Mlig455_028354 {REF} {Length: 2036} {RNA1310_45498} {RNA815_15412} | |
| 22. | MligTC455_16974 | 15 | 0.32 | Mlig455_052824 | Neo: - Age: - |
1.912 | 0.994 | - | - | - | 0.918 | - | Mlig455_052824 {REF} {Length: 306} {NoTransDecoderORF} {RNA1310_65069} {RNA815_35708.2} | |
| 23. | MligTC455_43979 | 188 | 3.92 | Mlig455_000082, Mlig455_063749 | Neo: - Age: - |
GHSR | 1.912 | 0.988 | - | - | - | 0.924 | - | Mlig455_000082 {REF} {Length: 1342} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=53.1]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=18.2]} {Human: ENSG00000121853, GHSR, growth hormone secretagogue receptor, [Score=52.0, Expect=7e-07]} {Mouse: ENSMUSG00000051136, Ghsr, growth hormone secretagogue receptor, [Score=50.4, Expect=2e-06]} {Celegans: WBGene00018798, gnrr-1, GoNadotropin-Releasing hormone Receptor (GnRHR) related, [Score=48.9, Expect=3e-06]} {Smed: dd_Smed_v6_60346_0_1, dd_Smed_v6_60346_0_1, [RH, Score=160, Expect=9e-47]} {RNA1310_30553} Mlig455_063749 {REF} {Length: 1323} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=48.3]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=20.4]} {Smed: dd_Smed_v6_60346_0_1, dd_Smed_v6_60346_0_1, [RH, Score=157, Expect=1e-45]} {RNA1310_30553} |
| 24. | MligTC455_51559 | 43 | 0.89 | Mlig455_002923, Mlig455_002941 | Neo: - Age: - Region-enriched R2: 6.806/0.01463 |
1.906 | 0.988 | - | - | - | 0.918 | - | Mlig455_002923 {REF} {Length: 1008} {RNA1310_77227} {RNA815_43894} Mlig455_002941 {REF} {Length: 897} {RNA1310_88681} {RNA815_43894} |
|
| 25. | MligTC455_10228 | 50 | 1.05 | Mlig455_023553 | Neo: - Age: - |
1.904 | 0.987 | - | - | - | 0.917 | - | Mlig455_023553 {REF} {Length: 1195} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=20.0]} {RNA1310_22533.1} {RNA815_23050} | |
| 26. | MligTC455_19487 | 14 | 0.28 | Mlig455_044811, Mlig455_055571 | Neo: - Age: - |
KCTD15 | 1.902 | 0.984 | - | - | - | 0.918 | - | Mlig455_044811 {REF} {Length: 1188} {Pfam: BTB/POZ domain [PF02214.24, score=67.6]} {Human: ENSG00000153885, KCTD15, potassium channel tetramerization domain containing 15, [RH, Score=253, Expect=3e-83]; ENSG00000134504, KCTD1, potassium channel tetramerization domain containing 1, [RH, Score=243, Expect=1e-73]} {Mouse: ENSMUSG00000030499, Kctd15, potassium channel tetramerisation domain containing 15, [RH, Score=254, Expect=6e-84]; ENSMUSG00000036225, Kctd1, potassium channel tetramerisation domain containing 1, [RH, Score=243, Expect=1e-73]} {Dmel: FBgn0034636, twz, tiwaz, [RH, Score=252, Expect=2e-82]} {Celegans: WBGene00016549, C40A11.6, [Score=57.4, Expect=1e-09]} {Smed: dd_Smed_v6_28887_0_1, dd_Smed_v6_28887_0_1, [RH, Score=184, Expect=3e-56]} {RNA1509_6075} {RNA1310_4175} {RNA815_1202.1} Mlig455_055571 {REF} {Length: 1181} {Pfam: BTB/POZ domain [PF02214.24, score=67.2]} {Human: ENSG00000153885, KCTD15, potassium channel tetramerization domain containing 15, [RH, Score=253, Expect=3e-83]; ENSG00000134504, KCTD1, potassium channel tetramerization domain containing 1, [RH, Score=243, Expect=2e-73]} {Mouse: ENSMUSG00000030499, Kctd15, potassium channel tetramerisation domain containing 15, [RH, Score=254, Expect=6e-84]; ENSMUSG00000036225, Kctd1, potassium channel tetramerisation domain containing 1, [RH, Score=243, Expect=1e-73]} {Dmel: FBgn0034636, twz, tiwaz, [RH, Score=250, Expect=1e-81]} {Celegans: WBGene00016549, C40A11.6, [Score=57.4, Expect=1e-09]} {Smed: dd_Smed_v6_28887_0_1, dd_Smed_v6_28887_0_1, [RH, Score=185, Expect=9e-57]} {RNA1509_6075} {RNA1310_4175} {RNA815_1202.1} |
| 27. | MligTC455_19616 | 70 | 1.46 | Mlig455_045100 | Neo: - Age: - |
RPH3A | 1.902 | 0.931 | - | - | - | 0.971 | - | Mlig455_045100 {REF} {Length: 2276} {Pfam: C2 domain [PF00168.32, score=141.3]} {Human: ENSG00000089169, RPH3A, rabphilin 3A, [RH, Score=247, Expect=9e-73]} {Mouse: ENSMUSG00000029608, Rph3a, rabphilin 3A, [RH, Score=244, Expect=9e-72]} {Dmel: FBgn0030230, Rph, Rabphilin, [Score=179, Expect=2e-50]} {Celegans: WBGene00004316, rbf-1, Rabphilin-1, [Score=209, Expect=6e-58]} {Smed: dd_Smed_v6_12977_0_1, dd_Smed_v6_12977_0_1, [Score=216, Expect=3e-62]} {RNA1310_30378} {RNA815_36857} |
| 28. | MligTC455_10226 | 119 | 2.48 | Mlig455_023508, Mlig455_023518, Mlig455_023617 | Neo: - Age: - |
1.901 | 0.984 | - | - | - | 0.917 | - | Mlig455_023508 {REF} {Length: 1311} {RNA1310_22533.2} {RNA815_23050} Mlig455_023518 {REF} {Length: 1413} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=21.5]} {RNA1310_22533.2} {RNA815_23050} Mlig455_023617 {REF} {Length: 1414} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=19.6]} {RNA1310_22533.2} {RNA815_23050} |
|
| 29. | MligTC455_19328 | 99 | 2.06 | Mlig455_062531 | Neo: - Age: Down-Up-Down Region-enriched R2: 4.972/0.00232 |
1.899 | 0.901 | - | - | - | 0.998 | - | Mlig455_062531 {REF} {Length: 1929} {NoTransDecoderORF} {RNA1509_36058} {RNA1310_3092} {RNA815_16673} | |
| 30. | MligTC455_51386 | 763 | 15.89 | Mlig455_041336, Mlig455_056222 | Neo: - Age: - Region-enriched R2: 3.643/0.00016 |
HPGDS | 1.898 | 0.963 | - | - | - | 0.935 | - | Mlig455_041336 {REF} {Length: 1363} {Pfam: Glutathione S-transferase, C-terminal domain [PF14497.8, score=46.9]; Glutathione S-transferase, N-terminal domain [PF02798.22, score=34.8]; Glutathione S-transferase, N-terminal domain [PF13409.8, score=23.3]; Glutathione S-transferase, N-terminal domain [PF13417.8, score=22.4]} {Human: ENSG00000163106, HPGDS, hematopoietic prostaglandin D synthase, [Score=74.7, Expect=2e-15]} {Mouse: ENSMUSG00000029919, Hpgds, hematopoietic prostaglandin D synthase, [Score=82.4, Expect=2e-18]} {Celegans: WBGene00001756, gst-8, Probable glutathione S-transferase 8, [Score=92.8, Expect=2e-22]} {Smed: dd_Smed_v6_1206_0_1, dd_Smed_v6_1206_0_1, [Score=79.0, Expect=2e-17]} {RNA1509_56224} {RNA1310_31890.2} {RNA815_14778} Mlig455_056222 {REF} {Length: 1343} {Pfam: Glutathione S-transferase, C-terminal domain [PF14497.8, score=62.1]; Glutathione S-transferase, N-terminal domain [PF02798.22, score=34.8]; Glutathione S-transferase, C-terminal domain [PF00043.27, score=31.1]; Glutathione S-transferase, N-terminal domain [PF13409.8, score=23.4]; Glutathione S-transferase, N-terminal domain [PF13417.8, score=22.5]; Glutathione S-transferase, C-terminal domain [PF13410.8, score=21.8]} {Human: ENSG00000163106, HPGDS, hematopoietic prostaglandin D synthase, [Score=78.2, Expect=8e-17]} {Mouse: ENSMUSG00000029919, Hpgds, hematopoietic prostaglandin D synthase, [Score=85.5, Expect=1e-19]} {Celegans: WBGene00001750, gst-2, Glutathione S-transferase 2, [RH, Score=96.7, Expect=3e-24]} {Smed: dd_Smed_v6_1206_0_1, dd_Smed_v6_1206_0_1, [Score=84.3, Expect=2e-19]} {RNA1509_56224} {RNA1310_31890.2} {RNA815_14778} |
| 31. | MligTC455_17363 | 62 | 1.28 | Mlig455_003936 | Neo: - Age: - |
1.895 | 0.988 | - | - | - | 0.907 | - | Mlig455_003936 {REF} {Length: 1252} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=45.9]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=26.4]} {RNA1310_47889} {RNA815_24646} | |
| 32. | MligTC455_41382 | 65 | 1.35 | Mlig455_022554 | Neo: - Age: - Region-enriched R2: 5.596/0.01432 |
1.895 | 0.988 | - | - | - | 0.907 | - | Mlig455_022554 {REF} {Length: 503} {Pfam: Pancreatic hormone peptide [PF00159.20, score=18.9]} {RNA1310_81495} {RNA815_42745} | |
| 33. | MligTC455_12512 | 80 | 1.68 | Mlig455_017689 | Neo: - Age: - |
1.892 | 0.988 | - | - | - | 0.904 | - | Mlig455_017689 {REF} {Length: 934} {RNA1310_37507} {RNA815_32171} | |
| 34. | MligTC455_43554 | 87 | 1.81 | Mlig455_007397, Mlig455_007495 | Neo: - Age: - Region-enriched R2: 5.819/0.00092 |
KCNMA1 | 1.891 | 0.891 | - | - | - | 1.000 | - | Mlig455_007397 {REF} {Length: 4419} {Pfam: Calcium-activated BK potassium channel alpha subunit [PF03493.20, score=109.4]; Ion transport protein [PF00520.33, score=59.4]; Ion channel [PF07885.18, score=53.7]; TrkA-N domain [PF02254.20, score=19.8]} {Human: ENSG00000156113, KCNMA1, potassium calcium-activated channel subfamily M alpha 1, [RH, Score=1128, Expect=0.0]} {Mouse: ENSMUSG00000063142, Kcnma1, potassium large conductance calcium-activated channel, subfamily M, alpha member 1, [RH, Score=1121, Expect=0.0]} {Dmel: FBgn0003429, slo, slowpoke, [RH, Score=1205, Expect=0.0]} {Celegans: WBGene00004830, slo-1, Calcium-activated potassium channel slo-1, [RH, Score=1127, Expect=0.0]} {Smed: dd_Smed_v6_5509_0_1, dd_Smed_v6_5509_0_1, [RH, Score=1165, Expect=0.0]} {RNA1509_27885} {RNA1310_2876} {RNA815_9989} Mlig455_007495 {REF} {Length: 4518} {Pfam: Calcium-activated BK potassium channel alpha subunit [PF03493.20, score=109.4]; Ion transport protein [PF00520.33, score=59.7]; Ion channel [PF07885.18, score=53.6]; TrkA-N domain [PF02254.20, score=20.1]} {Human: ENSG00000156113, KCNMA1, potassium calcium-activated channel subfamily M alpha 1, [RH, Score=1134, Expect=0.0]} {Mouse: ENSMUSG00000063142, Kcnma1, potassium large conductance calcium-activated channel, subfamily M, alpha member 1, [RH, Score=1128, Expect=0.0]} {Dmel: FBgn0003429, slo, slowpoke, [RH, Score=1212, Expect=0.0]} {Celegans: WBGene00004830, slo-1, Calcium-activated potassium channel slo-1, [RH, Score=1129, Expect=0.0]} {Smed: dd_Smed_v6_5509_0_1, dd_Smed_v6_5509_0_1, [RH, Score=1165, Expect=0.0]} {RNA1509_27885} {RNA1310_2876} {RNA815_9989} |
| 35. | MligTC455_08408 | 41 | 0.86 | Mlig455_043171 | Neo: - Age: Up-Down-Down |
1.89 | 0.988 | - | - | - | 0.902 | - | Mlig455_043171 {REF} {Length: 1568} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=19.4]} {RNA1310_47844} {RNA815_49360} | |
| 36. | MligTC455_44966 | 574 | 11.95 | Mlig455_036578, Mlig455_057773 | Neo: - Age: Down-Down-Up, logFC(26M/2M)=-0.756 Region-specific R2: 7.016 Region-enriched R2: 7.690/0.00000 |
1.89 | 0.988 | - | - | - | 0.902 | - | Mlig455_036578 {REF} {Length: 1101} {RNA1509_34765} {RNA1310_57079} {RNA815_29388} Mlig455_057773 {REF} {Length: 629} {RNA1509_34765} {RNA1310_57079, RNA1509_34765} {RNA1509_34765, RNA815_29388} |
|
| 37. | MligTC455_18333 | 273 | 5.7 | Mlig455_010935 | Neo: - Age: Down-Up-Up Region-enriched R2: 5.059/0.00307 |
1.889 | 0.962 | - | - | - | 0.927 | - | Mlig455_010935 {REF} {Length: 510} {RNA1310_33328.2} {RNA815_15093.1} | |
| 38. | MligTC455_21966 | 27 | 0.56 | Mlig455_005716 | Neo: - Age: - |
1.889 | 0.962 | - | - | - | 0.927 | - | Mlig455_005716 {REF} {Length: 4013} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=186.5]} {Mouse: ENSMUSG00000030873, Scnn1b, sodium channel, nonvoltage-gated 1 beta, [Score=52.4, Expect=1e-06]} {Smed: dd_Smed_v6_23771_0_1, dd_Smed_v6_23771_0_1, [RH, Score=382, Expect=2e-124]} {RNA1509_57431} {RNA1310_11500} {RNA815_5893} | |
| 39. | MligTC455_36193 | 13 | 0.27 | Mlig455_025794 | Neo: - Age: - |
B3GNT4 | 1.888 | 0.981 | - | - | - | 0.907 | - | Mlig455_025794 {REF} {Length: 3112} {Pfam: Galactosyltransferase [PF01762.23, score=116.7]} {Human: ENSG00000176383, B3GNT4, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4, [Score=101, Expect=5e-23]} {Mouse: ENSMUSG00000031803, B3gnt3, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3, [Score=94.7, Expect=1e-20]; ENSMUSG00000051650, B3gnt2, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2, [Score=94.0, Expect=2e-20]; ENSMUSG00000029431, B3gnt4, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4, [Score=93.2, Expect=2e-20]; ENSMUSG00000067370, B3galt4, UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 4, [Score=93.2, Expect=3e-20]; ENSMUSG00000022686, B3gnt5, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5, [Score=91.7, Expect=1e-19]} {Dmel: FBgn0031988, CG8668, [Score=89.7, Expect=1e-18]} {Celegans: WBGene00007104, B0024.15, Hexosyltransferase, [RH, Score=90.9, Expect=8e-20]} {Smed: dd_Smed_v6_9789_0_1, dd_Smed_v6_9789_0_1, [Score=165, Expect=5e-47]} {RNA1310_43172} {RNA815_26726} |
| 40. | MligTC455_26356 | 62 | 1.3 | Mlig455_042551 | Neo: - |
GRIK2 | 1.887 | 0.987 | - | - | - | 0.900 | - | Mlig455_042551 {REF} {Length: 2917} {Pfam: Ligand-gated ion channel [PF00060.28, score=82.2]; Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=60.7]; Receptor family ligand binding region [PF01094.30, score=32.2]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=27.3]} {Human: ENSG00000164418, GRIK2, glutamate ionotropic receptor kainate type subunit 2, [Score=144, Expect=9e-35]; ENSG00000152208, GRID2, glutamate ionotropic receptor delta type subunit 2, [Score=141, Expect=7e-34]} {Mouse: ENSMUSG00000056073, Grik2, glutamate receptor, ionotropic, kainate 2 (beta 2), [Score=143, Expect=1e-34]; ENSMUSG00000071424, Grid2, glutamate receptor, ionotropic, delta 2, [Score=142, Expect=2e-34]} {Dmel: FBgn0051201, GluRIIE, Glutamate receptor IIE, [Score=119, Expect=3e-27]} {Celegans: WBGene00001616, glr-5, GLutamate Receptor family (AMPA), [Score=123, Expect=2e-28]} {Smed: dd_Smed_v6_21015_0_1, dd_Smed_v6_21015_0_1, [Score=247, Expect=4e-74]} {RNA1310_21865} {RNA815_26044} |
| 41. | MligTC455_35813 | 35 | 0.73 | Mlig455_013562, Mlig455_013615 | Neo: - Age: - Region-enriched R2: 7.733/0.00085 |
NPR2 | 1.887 | 0.988 | - | - | - | 0.899 | - | Mlig455_013562 {REF} {Length: 3105} {Pfam: Adenylate and Guanylate cyclase catalytic domain [PF00211.22, score=187.6]; Nitrate and nitrite sensing [PF08376.12, score=108.9]; Heme NO binding associated [PF07701.16, score=29.1]} {Human: ENSG00000159899, NPR2, natriuretic peptide receptor 2, [Score=251, Expect=2e-70]; ENSG00000169418, NPR1, natriuretic peptide receptor 1, [Score=247, Expect=6e-69]; ENSG00000101890, GUCY2F, guanylate cyclase 2F, retinal, [Score=241, Expect=1e-66]} {Mouse: ENSMUSG00000028469, Npr2, natriuretic peptide receptor 2, [Score=252, Expect=1e-73]; ENSMUSG00000027931, Npr1, natriuretic peptide receptor 1, [Score=248, Expect=2e-69]} {Dmel: FBgn0053958, CG33958, [Score=330, Expect=3e-102]} {Celegans: WBGene00001533, gcy-6, Receptor-type guanylate cyclase gcy-6, [Score=231, Expect=7e-64]} {Smed: dd_Smed_v6_11767_0_1, dd_Smed_v6_11767_0_1, [Score=244, Expect=3e-68]} {RNA1310_16282} {RNA815_27869} Mlig455_013615 {REF} {Length: 2993} {Pfam: Adenylate and Guanylate cyclase catalytic domain [PF00211.22, score=187.7]; Nitrate and nitrite sensing [PF08376.12, score=109.5]; Heme NO binding associated [PF07701.16, score=29.1]} {Human: ENSG00000159899, NPR2, natriuretic peptide receptor 2, [Score=251, Expect=2e-70]; ENSG00000169418, NPR1, natriuretic peptide receptor 1, [Score=246, Expect=8e-69]; ENSG00000101890, GUCY2F, guanylate cyclase 2F, retinal, [Score=241, Expect=1e-66]} {Mouse: ENSMUSG00000028469, Npr2, natriuretic peptide receptor 2, [Score=252, Expect=9e-74]; ENSMUSG00000027931, Npr1, natriuretic peptide receptor 1, [Score=247, Expect=2e-69]} {Dmel: FBgn0053958, CG33958, [Score=331, Expect=1e-102]} {Celegans: WBGene00001533, gcy-6, Receptor-type guanylate cyclase gcy-6, [Score=231, Expect=8e-64]} {Smed: dd_Smed_v6_11767_0_1, dd_Smed_v6_11767_0_1, [Score=244, Expect=3e-68]} {RNA1310_16282} {RNA815_33407} |
| 42. | MligTC455_11701 | 54 | 1.12 | Mlig455_042837, Mlig455_045855, Mlig455_045871 | Neo: - Age: - |
1.885 | 0.988 | - | - | - | 0.897 | - | Mlig455_042837 {REF} {Length: 487} {RNA1310_85827} {RNA815_46819} Mlig455_045855 {REF} {Length: 487} {RNA1310_85827} {RNA815_46819} Mlig455_045871 {REF} {Length: 487} {RNA1310_85827} {RNA815_46819} |
|
| 43. | MligTC455_48692 | 15 | 0.32 | Mlig455_021398 | Neo: - Age: - Region-enriched R2: 8.096/0.02429 |
1.885 | 0.975 | - | - | - | 0.910 | - | Mlig455_021398 {REF} {Length: 1571} {Pfam: Ankyrin repeat [PF00023.32, score=20.9]; Ankyrin repeats (many copies) [PF13637.8, score=20.4]; Ankyrin repeats (many copies) [PF13857.8, score=19.6]; Ankyrin repeats (3 copies) [PF12796.9, score=19.4]} {Smed: dd_Smed_v6_29956_0_1, dd_Smed_v6_29956_0_1, [Score=54.7, Expect=3e-08]} {RNA1310_69005} | |
| 44. | MligTC455_33280 | 127 | 2.64 | Mlig455_010523 | Neo: - Age: Down-Up-Up |
1.882 | 0.962 | - | - | - | 0.920 | - | Mlig455_010523 {REF} {Length: 587} {RNA1509_48963} {RNA1310_65789} {RNA815_23468} | |
| 45. | MligTC455_46720 | 10 | 0.21 | Mlig455_053856 | Neo: - |
NPR1 | 1.882 | 0.978 | - | - | - | 0.904 | - | Mlig455_053856 {REF} {Length: 2671} {Pfam: Adenylate and Guanylate cyclase catalytic domain [PF00211.22, score=99.0]; Nitrate and nitrite sensing [PF08376.12, score=81.9]} {Human: ENSG00000169418, NPR1, natriuretic peptide receptor 1, [Score=154, Expect=2e-38]; ENSG00000159899, NPR2, natriuretic peptide receptor 2, [Score=151, Expect=2e-37]} {Mouse: ENSMUSG00000027931, Npr1, natriuretic peptide receptor 1, [Score=153, Expect=3e-38]; ENSMUSG00000028469, Npr2, natriuretic peptide receptor 2, [Score=151, Expect=2e-38]; ENSMUSG00000055523, Gucy2g, guanylate cyclase 2g, [Score=150, Expect=3e-37]; ENSMUSG00000020890, Gucy2e, guanylate cyclase 2e, [Score=149, Expect=5e-37]} {Dmel: FBgn0053958, CG33958, [Score=211, Expect=1e-58]} {Celegans: WBGene00001547, gcy-22, Receptor-type guanylate cyclase gcy-22, [Score=152, Expect=4e-38]} {Smed: dd_Smed_v6_9453_0_1, dd_Smed_v6_9453_0_1, [Score=158, Expect=4e-40]} {RNA1310_55195} |
| 46. | MligTC455_09510 | 314 | 6.55 | Mlig455_001134, Mlig455_042048 | Neo: - Age: - Region-specific R2: 5.291 Region-enriched R2: 5.151/0.00029 |
1.879 | 0.956 | - | - | - | 0.923 | - | Mlig455_001134 {REF} {Length: 485} {Pfam: Fingers domain of DNA polymerase lambda [PF10391.11, score=26.9]} {RNA1310_8738.1} {RNA815_21682.1} Mlig455_042048 {REF} {Length: 1550} {Pfam: Fingers domain of DNA polymerase lambda [PF10391.11, score=32.1]} {Dmel: FBgn0036416, CG7924, [RH, Score=61.2, Expect=1e-10]} {RNA1509_51261} {RNA1310_8738.1} {RNA815_21682.1} |
|
| 47. | MligTC455_42484 | 246 | 5.12 | Mlig455_046416 | Neo: - Age: Down-Up-Down Region-specific R2: 4.313 Region-enriched R2: 2.983/0.00930 |
1.878 | 0.953 | - | - | - | 0.925 | - | Mlig455_046416 {REF} {Length: 1006} {RNA1310_40237.1} {RNA815_18246} | |
| 48. | MligTC455_44713 | 661 | 13.77 | Mlig455_048154 | Neo: - Age: logFC(26M/2M)=0.569 Region-specific R2: 3.883 Region-enriched R2: 3.422/0.00000 |
1.877 | 0.926 | - | - | - | 0.951 | - | Mlig455_048154 {REF} {Length: 1173} {RNA1509_34252} {RNA1310_54269.1} {RNA815_55074} | |
| 49. | MligTC455_45487 | 110 | 2.3 | Mlig455_004129, Mlig455_060457 | Neo: - Age: - |
1.877 | 0.988 | - | - | - | 0.889 | - | Mlig455_004129 {REF} {Length: 1131} {Pfam: PAN domain [PF00024.28, score=18.8]} {Smed: dd_Smed_v6_32483_0_1, dd_Smed_v6_32483_0_1, [Score=64.3, Expect=2e-12]} {RNA1310_37660} {RNA815_17816.1} Mlig455_060457 {REF} {Length: 1507} {Pfam: PAN domain [PF00024.28, score=19.5]} {Smed: dd_Smed_v6_32483_0_1, dd_Smed_v6_32483_0_1, [Score=64.3, Expect=2e-12]} {RNA1509_54623} {RNA1310_33480} {RNA815_17816.1} |
|
| 50. | MligTC455_15215 | 22 | 0.46 | Mlig455_037928 | Neo: - Age: - |
CHRNA9 | 1.876 | - | - | 0.908 | - | 0.968 | - | Mlig455_037928 {REF} {Length: 2079} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=180.0]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=57.1]} {Human: ENSG00000174343, CHRNA9, cholinergic receptor nicotinic alpha 9 subunit, [Score=221, Expect=7e-65]; ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=220, Expect=2e-64]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=220, Expect=2e-64]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=218, Expect=9e-64]; ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=216, Expect=2e-63]} {Mouse: ENSMUSG00000029205, Chrna9, cholinergic receptor, nicotinic, alpha polypeptide 9, [Score=222, Expect=1e-65]; ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=219, Expect=3e-64]; ENSMUSG00000066279, Chrna10, cholinergic receptor, nicotinic, alpha polypeptide 10, [Score=214, Expect=7e-63]} {Dmel: FBgn0028875, nAChRalpha5, nicotinic Acetylcholine Receptor alpha5, [Score=228, Expect=2e-65]} {Celegans: WBGene00000058, acr-19, AcetylCholine Receptor; Acetylcholine receptor (63.2 kD) (Acr-19), [Score=221, Expect=6e-65]} {Smed: dd_Smed_v6_31300_0_1, dd_Smed_v6_31300_0_1, [Score=214, Expect=1e-62]} {RNA1310_88831} |
| 51. | MligTC455_25701 | 31 | 0.65 | Mlig455_017477 | Neo: - Age: - |
1.876 | 0.988 | - | - | - | 0.888 | - | Mlig455_017477 {REF} {Length: 664} {RNA1310_52753} {RNA815_26527} | |
| 52. | MligTC455_52164 | 49 | 1.01 | Mlig455_019248 | Neo: - Age: Down-Up-Up Region-enriched R1: 12.972/0.02781 |
1.874 | 0.952 | - | - | - | 0.922 | - | Mlig455_019248 {REF} {Length: 923} {Celegans: WBGene00015646, mlt-10, [Score=98.2, Expect=4e-23]} {RNA1509_24360} {RNA1310_75398} {RNA815_40298} | |
| 53. | MligTC455_15949 | 37 | 0.76 | Mlig455_059880 | Neo: - Age: - |
1.871 | 0.965 | - | - | - | 0.906 | - | Mlig455_059880 {REF} {Length: 1226} {Pfam: Lectin C-type domain [PF00059.23, score=39.5]} {Dmel: FBgn0031373, CG15358, [Score=52.8, Expect=4e-08]} {RNA1310_120903} | |
| 54. | MligTC455_12183 | 53 | 1.11 | Mlig455_004166, Mlig455_004190 | Neo: - Age: - Region-enriched R2: 4.930/0.01881 |
1.869 | 0.991 | - | - | - | 0.878 | - | Mlig455_004166 {REF} {Length: 2818} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=57.4]; Serpentine type 7TM GPCR chemoreceptor Srbc [PF10316.11, score=29.1]} {Celegans: WBGene00019019, frpr-10, FMRFamide Peptide Receptor family, [Score=55.5, Expect=1e-08]} {Smed: dd_Smed_v6_70862_0_1, dd_Smed_v6_70862_0_1, [Score=60.8, Expect=8e-12]} {RNA1310_64973} {RNA815_58453} Mlig455_004190 {REF} {Length: 2742} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=56.7]; Serpentine type 7TM GPCR chemoreceptor Srbc [PF10316.11, score=28.6]} {Celegans: WBGene00019019, frpr-10, FMRFamide Peptide Receptor family, [Score=56.2, Expect=1e-08]} {Smed: dd_Smed_v6_70862_0_1, dd_Smed_v6_70862_0_1, [Score=60.8, Expect=1e-11]} {RNA1310_62602} {RNA815_58453} |
|
| 55. | MligTC455_25703 | 225 | 4.7 | Mlig455_017402, Mlig455_030916 | Neo: - Age: - |
1.869 | 0.988 | - | - | - | 0.881 | - | Mlig455_017402 {REF} {Length: 899} {RNA1310_52753} {RNA815_26527} Mlig455_030916 {REF} {Length: 700} {RNA1310_52753} {RNA815_26527} |
|
| 56. | MligTC455_47780 | 214 | 4.46 | Mlig455_018842, Mlig455_018853 | Neo: - Age: - |
1.865 | 0.911 | - | - | - | 0.954 | - | Mlig455_018842 {REF} {Length: 500} {RNA1509_48336} {RNA1310_73351} {RNA815_41082} Mlig455_018853 {REF} {Length: 593} {RNA1509_48336} {RNA1310_73351, RNA1509_48336} {RNA1509_48336, RNA815_41082} |
|
| 57. | MligTC455_41449 | 60 | 1.25 | Mlig455_063380 | Neo: - Age: Down-Up-Up |
1.864 | 0.902 | - | - | - | 0.962 | - | Mlig455_063380 {REF} {Length: 673} {RNA1310_71257} {RNA815_40073} | |
| 58. | MligTC455_24407 | 222 | 4.63 | Mlig455_044026 | Neo: - Age: Down-Up-Up Region-specific R2: 3.725 Region-enriched R2: 3.414/0.00001 |
1.863 | 0.892 | - | - | - | 0.971 | - | Mlig455_044026 {REF} {Length: 503} {RNA1509_54091} {RNA1310_68348.1} {RNA815_33570.1} | |
| 59. | MligTC455_46721 | 8 | 0.16 | Mlig455_053871 | Neo: - Age: - |
NPR1 | 1.863 | 0.982 | - | - | - | 0.881 | - | Mlig455_053871 {REF} {Length: 2774} {Pfam: Adenylate and Guanylate cyclase catalytic domain [PF00211.22, score=100.4]; Nitrate and nitrite sensing [PF08376.12, score=82.7]} {Human: ENSG00000169418, NPR1, natriuretic peptide receptor 1, [Score=156, Expect=5e-39]; ENSG00000159899, NPR2, natriuretic peptide receptor 2, [Score=152, Expect=7e-38]} {Mouse: ENSMUSG00000027931, Npr1, natriuretic peptide receptor 1, [Score=155, Expect=7e-39]; ENSMUSG00000028469, Npr2, natriuretic peptide receptor 2, [Score=152, Expect=9e-39]; ENSMUSG00000020890, Gucy2e, guanylate cyclase 2e, [Score=151, Expect=1e-37]; ENSMUSG00000055523, Gucy2g, guanylate cyclase 2g, [Score=149, Expect=5e-37]} {Dmel: FBgn0053958, CG33958, [Score=212, Expect=2e-59]} {Celegans: WBGene00001547, gcy-22, Receptor-type guanylate cyclase gcy-22, [Score=154, Expect=9e-39]} {Smed: dd_Smed_v6_9453_0_1, dd_Smed_v6_9453_0_1, [Score=159, Expect=2e-40]} {RNA1310_55195} |
| 60. | MligTC455_47420 | 218 | 4.54 | Mlig455_017159, Mlig455_048110 | Neo: - Age: - Region-specific R2: 6.469 Region-enriched R2: 5.851/0.00135 |
1.863 | 0.963 | - | - | - | 0.900 | - | Mlig455_017159 {REF} {Length: 1062} {RNA1509_35349} {RNA1310_81586} Mlig455_048110 {REF} {Length: 527} {RNA1310_81586} |
|
| 61. | MligTC455_17468 | 54 | 1.13 | Mlig455_013421 | Neo: - Age: - Region-enriched R2: 9.270/0.00000 |
LUZP4 | 1.861 | 0.878 | - | - | - | 0.983 | - | Mlig455_013421 {REF} {Length: 1578} {Human: ENSG00000102021, LUZP4, leucine zipper protein 4, [RH, Score=62.8, Expect=5e-11]} {RNA1310_64423.1} {RNA815_29788} |
| 62. | MligTC455_18099 | 24 | 0.51 | Mlig455_036525 | Neo: - Age: - |
PPA1 | 1.861 | 0.988 | - | - | - | 0.873 | - | Mlig455_036525 {REF} {Length: 1911} {Pfam: Inorganic pyrophosphatase [PF00719.21, score=181.8]} {Human: ENSG00000180817, PPA1, pyrophosphatase (inorganic) 1, [Score=304, Expect=2e-103]; ENSG00000138777, PPA2, pyrophosphatase (inorganic) 2, [Score=295, Expect=4e-99]} {Mouse: ENSMUSG00000020089, Ppa1, pyrophosphatase (inorganic) 1, [Score=307, Expect=9e-105]} {Dmel: FBgn0016687, Nurf-38, Nucleosome remodeling factor - 38kD, [Score=303, Expect=2e-103]} {Celegans: WBGene00008149, pyp-1, Probable inorganic pyrophosphatase 1, [Score=315, Expect=5e-108]} {Smed: dd_Smed_v6_625_0_1, dd_Smed_v6_625_0_1, [Score=290, Expect=2e-98]} {RNA1310_57333.1} {RNA815_22340} |
| 63. | MligTC455_27313 | 61 | 1.27 | Mlig455_031814, Mlig455_047613 | Neo: - Age: - |
WSCD2 | 1.861 | 0.988 | - | - | - | 0.873 | - | Mlig455_031814 {REF} {Length: 844} {Pfam: WSC domain [PF01822.21, score=66.1]; PAN domain [PF00024.28, score=19.7]} {Human: ENSG00000075035, WSCD2, WSC domain containing 2, [Score=62.0, Expect=7e-11]} {Mouse: ENSMUSG00000063430, Wscd2, WSC domain containing 2, [Score=60.5, Expect=1e-10]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=56.6, Expect=3e-09]} {Celegans: WBGene00005024, sqv-6, Xylosyltransferase sqv-6, [Score=48.5, Expect=1e-06]} {RNA1509_43359} {RNA1310_33892} {RNA815_23776.1} Mlig455_047613 {REF} {Length: 843} {Pfam: WSC domain [PF01822.21, score=52.5]; PAN domain [PF00024.28, score=19.2]} {Human: ENSG00000075035, WSCD2, WSC domain containing 2, [Score=52.0, Expect=5e-08]} {Mouse: ENSMUSG00000063430, Wscd2, WSC domain containing 2, [Score=48.9, Expect=4e-07]} {RNA1509_43359} {RNA1310_33892} {RNA815_23776.1} |
| 64. | MligTC455_29408 | 45 | 0.94 | Mlig455_038322 | Neo: - Age: - Region-enriched R2: 8.586/0.00762 |
MB | 1.86 | 0.980 | - | - | - | 0.880 | - | Mlig455_038322 {REF} {Length: 2059} {Pfam: Globin [PF00042.24, score=57.8]} {Human: ENSG00000198125, MB, myoglobin, [RH, Score=47.8, Expect=5e-07]} {Mouse: ENSMUSG00000018893, Mb, myoglobin, [RH, Score=45.4, Expect=2e-06]} {Celegans: WBGene00008996, glb-14, GLoBin related, [Score=51.6, Expect=4e-08]} {Smed: dd_Smed_v6_15997_0_1, dd_Smed_v6_15997_0_1, [RH, Score=63.5, Expect=1e-12]} {RNA1509_48898} {RNA1310_47695} {RNA815_7096.1} |
| 65. | MligTC455_14483 | 140 | 2.92 | Mlig455_028240 | Neo: - Age: - Region-enriched R2: 6.203/0.04837 |
1.856 | 0.988 | - | - | - | 0.868 | - | Mlig455_028240 {REF} {Length: 728} {RNA1310_111517} {RNA815_9716} | |
| 66. | MligTC455_29317 | 89 | 1.85 | Mlig455_062533 | Neo: - Age: logFC(26M/2M)=0.866 |
SLC18A3 | 1.855 | 0.877 | - | - | - | 0.978 | - | Mlig455_062533 {REF} {Length: 3319} {Pfam: Major Facilitator Superfamily [PF07690.18, score=140.0]; LacY proton/sugar symporter [PF01306.21, score=22.0]} {Human: ENSG00000187714, SLC18A3, solute carrier family 18 member A3, [RH, Score=457, Expect=1e-155]} {Mouse: ENSMUSG00000100241, Slc18a3, solute carrier family 18 (vesicular monoamine), member 3, [RH, Score=462, Expect=8e-158]} {Dmel: FBgn0270928, VAChT, Vesicular acetylcholine transporter, [RH, Score=512, Expect=6e-177]} {Celegans: WBGene00006756, unc-17, Vesicular acetylcholine transporter unc-17, [RH, Score=474, Expect=6e-163]} {Smed: dd_Smed_v6_11630_0_1, dd_Smed_v6_11630_0_1, [RH, Score=535, Expect=0.0]} {RNA1509_22907} {RNA1310_5498.1, RNA1509_22907} {RNA1509_22907, RNA815_3951} |
| 67. | MligTC455_37047 | 45 | 0.94 | Mlig455_046180 | Neo: - Age: - |
1.845 | 0.964 | - | - | - | 0.881 | - | Mlig455_046180 {REF} {Length: 1686} {RNA1310_140241} {RNA815_12716} | |
| 68. | MligTC455_31933 | 105 | 2.18 | Mlig455_062083 | Neo: - Age: - |
ANGPTL1 | 1.843 | 0.965 | - | - | - | 0.878 | - | Mlig455_062083 {REF} {Length: 1024} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=156.7]} {Human: ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=135, Expect=7e-36]; ENSG00000136859, ANGPTL2, angiopoietin like 2, [Score=132, Expect=2e-34]; ENSG00000101280, ANGPT4, angiopoietin 4, [Score=132, Expect=9e-35]} {Mouse: ENSMUSG00000033544, Angptl1, angiopoietin-like 1, [Score=137, Expect=1e-36]; ENSMUSG00000038742, Angptl6, angiopoietin-like 6, [Score=132, Expect=4e-35]; ENSMUSG00000004105, Angptl2, angiopoietin-like 2, [Score=131, Expect=1e-34]} {Dmel: FBgn0034160, CG5550, [Score=130, Expect=2e-36]} {Celegans: WBGene00020516, T15B7.1, [Score=73.9, Expect=9e-15]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=126, Expect=2e-32]} {RNA1509_14033} {RNA1310_32107.2} {RNA815_17173.3} |
| 69. | MligTC455_15694 | 54 | 1.13 | Mlig455_026426, Mlig455_026456 | Neo: - Age: - Region-enriched R2: 6.151/0.00957 |
SSTR1 | 1.84 | 0.868 | - | - | - | 0.972 | - | Mlig455_026426 {REF} {Length: 2191} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=134.4]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=28.7]; Olfactory receptor [PF13853.8, score=26.6]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=21.2]} {Human: ENSG00000139874, SSTR1, somatostatin receptor 1, [Score=138, Expect=3e-36]} {Mouse: ENSMUSG00000035431, Sstr1, somatostatin receptor 1, [Score=140, Expect=6e-37]; ENSMUSG00000037014, Sstr4, somatostatin receptor 4, [Score=135, Expect=4e-35]} {Dmel: FBgn0036790, AstC-R1, Allatostatin C receptor 1, [Score=124, Expect=5e-31]} {Celegans: WBGene00013782, npr-32, NeuroPeptide Receptor family, [Score=111, Expect=1e-26]} {Smed: dd_Smed_v6_16055_0_1, dd_Smed_v6_16055_0_1, [Score=128, Expect=2e-33]} {RNA1310_38996} {RNA815_25059} Mlig455_026456 {REF} {Length: 2423} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=134.5]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=28.9]; Olfactory receptor [PF13853.8, score=26.7]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=21.3]} {Human: ENSG00000139874, SSTR1, somatostatin receptor 1, [Score=138, Expect=3e-36]} {Mouse: ENSMUSG00000035431, Sstr1, somatostatin receptor 1, [Score=140, Expect=5e-37]; ENSMUSG00000037014, Sstr4, somatostatin receptor 4, [Score=135, Expect=3e-35]} {Dmel: FBgn0036790, AstC-R1, Allatostatin C receptor 1, [Score=124, Expect=7e-31]} {Celegans: WBGene00013782, npr-32, NeuroPeptide Receptor family, [Score=110, Expect=2e-26]} {Smed: dd_Smed_v6_16055_0_1, dd_Smed_v6_16055_0_1, [Score=128, Expect=1e-33]} {RNA1310_38996} {RNA815_25059} |
| 70. | MligTC455_17021 | 49 | 1.02 | Mlig455_030263 | Neo: - Age: - |
1.835 | 0.985 | - | - | - | 0.850 | - | Mlig455_030263 {REF} {Length: 566} {TRANSSPLICED} {Pfam: Galactosyltransferase [PF01762.23, score=23.7]} {Dmel: FBgn0000221, brn, brainiac, [Score=45.8, Expect=1e-06]} {RNA1310_35735} {RNA815_59866} | |
| 71. | MligTC455_33772 | 104 | 2.17 | Mlig455_016493 | Neo: - Age: Down-Up-Up Region-enriched R2: 4.862/0.00025 |
1.834 | 0.883 | - | - | - | 0.951 | - | Mlig455_016493 {REF} {Length: 883} {RNA1310_43848} {RNA815_55624} | |
| 72. | MligTC455_42485 | 159 | 3.31 | Mlig455_046457 | Neo: - Age: - |
1.834 | 0.985 | - | - | - | 0.849 | - | Mlig455_046457 {REF} {Length: 846} {RNA1310_40237.1} {RNA815_18246} | |
| 73. | MligTC455_39222 | 213 | 4.44 | Mlig455_064653, Mlig455_064686 | Neo: - Age: - Region-enriched R2: 4.317/0.00597 |
1.829 | 0.984 | - | - | - | 0.845 | - | Mlig455_064653 {REF} {Length: 2836} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=56.8]} {Mouse: ENSMUSG00000039079, Trhr2, thyrotropin releasing hormone receptor 2, [Score=58.9, Expect=6e-09]} {Dmel: FBgn0053696, CNMaR, CNMamide Receptor, [Score=73.6, Expect=8e-14]} {Celegans: WBGene00008885, F16C3.1, [Score=51.2, Expect=7e-07]} {Smed: dd_Smed_v6_13282_0_1, dd_Smed_v6_13282_0_1, [RH, Score=219, Expect=1e-66]} {RNA1509_56255} {RNA1310_13407} {RNA815_38407} Mlig455_064686 {REF} {Length: 3820} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=56.8]} {Mouse: ENSMUSG00000039079, Trhr2, thyrotropin releasing hormone receptor 2, [Score=58.5, Expect=6e-09]} {Dmel: FBgn0053696, CNMaR, CNMamide Receptor, [Score=73.6, Expect=8e-14]} {Celegans: WBGene00008885, F16C3.1, [Score=51.2, Expect=8e-07]} {Smed: dd_Smed_v6_13282_0_1, dd_Smed_v6_13282_0_1, [RH, Score=219, Expect=1e-66]} {RNA1509_50956} {RNA1310_13407} {RNA815_38407} |
|
| 74. | MligTC455_11254 | 19 | 0.4 | Mlig455_060079 | Neo: - Age: - |
1.828 | 0.873 | - | - | - | 0.955 | - | Mlig455_060079 {REF} {Length: 1689} {Pfam: Glycine rich protein [PF12810.9, score=20.4]} | |
| 75. | MligTC455_38780 | 235 | 4.89 | Mlig455_000360, Mlig455_056487 | Neo: - Age: - Region-enriched R2: 3.921/0.00457 |
SGSM1 | 1.827 | 0.861 | - | - | - | 0.966 | - | Mlig455_000360 {REF} {Length: 3015} {Pfam: Rab-GTPase-TBC domain [PF00566.20, score=53.6]; RUN domain [PF02759.21, score=45.8]} {Human: ENSG00000167037, SGSM1, small G protein signaling modulator 1, [Score=170, Expect=8e-43]} {Mouse: ENSMUSG00000042216, Sgsm1, small G protein signaling modulator 1, [Score=165, Expect=2e-41]} {Dmel: FBgn0052506, CG32506, [Score=150, Expect=1e-36]} {Celegans: WBGene00008018, tbc-8, TBC (Tre-2/Bub2/Cdc16) domain family, [Score=184, Expect=7e-48]} {Smed: dd_Smed_v6_12130_0_1, dd_Smed_v6_12130_0_1, [Score=196, Expect=1e-51]} {RNA1310_67163} {RNA815_24450} Mlig455_056487 {REF} {Length: 3063} {Pfam: Rab-GTPase-TBC domain [PF00566.20, score=52.8]; RUN domain [PF02759.21, score=45.7]} {Human: ENSG00000167037, SGSM1, small G protein signaling modulator 1, [Score=171, Expect=6e-43]} {Mouse: ENSMUSG00000042216, Sgsm1, small G protein signaling modulator 1, [Score=166, Expect=2e-41]} {Dmel: FBgn0052506, CG32506, [Score=150, Expect=9e-37]} {Celegans: WBGene00008018, tbc-8, TBC (Tre-2/Bub2/Cdc16) domain family, [Score=183, Expect=2e-47]} {Smed: dd_Smed_v6_12130_0_1, dd_Smed_v6_12130_0_1, [Score=193, Expect=2e-50]} {RNA1310_67163} {RNA815_24450} |
| 76. | MligTC455_42650 | 33 | 0.69 | Mlig455_027379 | Neo: - Age: - |
1.826 | 0.980 | - | - | - | 0.846 | - | Mlig455_027379 {REF} {Length: 661} {RNA1310_47424} {RNA815_44231} | |
| 77. | MligTC455_17177 | 103 | 2.15 | Mlig455_048992, Mlig455_049009 | Neo: - Age: Down-Down-Up |
1.825 | 0.988 | - | - | - | 0.837 | - | Mlig455_048992 {REF} {Length: 1836} {RNA1509_44702} {RNA1310_14743, RNA1509_44702} {RNA1509_44702, RNA815_20669.1} Mlig455_049009 {REF} {Length: 1823} {RNA1509_44702} {RNA1310_14743} {RNA815_20669.1} |
|
| 78. | MligTC455_46880 | 44 | 0.91 | Mlig455_046271 | Neo: - Age: - |
IAH1 | 1.822 | 0.988 | - | - | - | 0.834 | - | Mlig455_046271 {REF} {Length: 1061} {Pfam: GDSL-like Lipase/Acylhydrolase family [PF13472.8, score=75.8]; GDSL-like Lipase/Acylhydrolase [PF00657.24, score=32.0]} {Human: ENSG00000134330, IAH1, isoamyl acetate hydrolyzing esterase 1 (putative), [Score=138, Expect=2e-39]} {Mouse: ENSMUSG00000062054, Iah1, isoamyl acetate-hydrolyzing esterase 1 homolog, [Score=121, Expect=4e-33]} {Smed: dd_Smed_v6_6241_0_1, dd_Smed_v6_6241_0_1, [Score=111, Expect=8e-30]} {RNA1310_130726} |
| 79. | MligTC455_52570 | 71 | 1.49 | Mlig455_066071 | Neo: - Age: Up-Down-Up |
1.819 | 0.988 | - | - | - | 0.831 | - | Mlig455_066071 {REF} {Length: 2575} {Pfam: Hemingway/CFA97 [PF13879.8, score=54.6]; Annexin [PF00191.22, score=26.1]} {Mouse: ENSMUSG00000090336, Cfap97d2, CFAP97 domain containing 2, [Score=46.6, Expect=3e-06]} {Smed: dd_Smed_v6_2676_0_1, dd_Smed_v6_2676_0_1, [Score=70.1, Expect=2e-13]} {RNA1310_29320.1} {RNA815_54680} | |
| 80. | MligTC455_43643 | 2324 | 48.41 | Mlig455_065102 | Neo: - Age: - Region-specific R2: 2.496 Region-enriched R2: 1.834/0.00001 Regeneration-downregulated R6: -1.642 Regeneration-depleted R6: -1.642 |
1.818 | 0.856 | - | - | - | 0.962 | - | Mlig455_065102 {REF} {Length: 850} {RNA1509_16353, RNA1509_24268} {RNA1310_47277.1, RNA1509_24268} {RNA1509_24268, RNA815_19145.2} | |
| 81. | MligTC455_40040 | 365 | 7.61 | Mlig455_008332 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=-0.784 Region-specific R2: 6.834 Region-enriched R2: 5.705/0.00005 |
1.814 | 0.982 | - | - | - | 0.832 | - | Mlig455_008332 {REF} {Length: 707} {RNA1509_39735} {RNA1310_73916, RNA1509_39735} {RNA1509_39735, RNA815_42730.2} | |
| 82. | MligTC455_43642 | 2199 | 45.81 | Mlig455_018475 | Neo: - Age: Down-Up-Up Region-specific R2: 2.701 Region-enriched R2: 2.110/0.00000 |
1.813 | 0.846 | - | - | - | 0.967 | - | Mlig455_018475 {REF} {Length: 949} {RNA1509_30521} {RNA1310_47277.3, RNA1509_30521} {RNA1509_30521, RNA815_19145.1} | |
| 83. | MligTC455_11732 | 15 | 0.32 | Mlig455_001499, Mlig455_001517 | Neo: - Age: - |
GABBR2 | 1.812 | 0.988 | - | - | - | 0.824 | - | Mlig455_001499 {REF} {Length: 2516} {Pfam: 7 transmembrane sweet-taste receptor of 3 GCPR [PF00003.24, score=166.2]; Receptor family ligand binding region [PF01094.30, score=21.1]} {Human: ENSG00000136928, GABBR2, gamma-aminobutyric acid type B receptor subunit 2, [Score=219, Expect=7e-61]} {Mouse: ENSMUSG00000039809, Gabbr2, gamma-aminobutyric acid (GABA) B receptor, 2, [Score=219, Expect=5e-61]} {Dmel: FBgn0027575, GABA-B-R2, metabotropic GABA-B receptor subtype 2, [Score=202, Expect=4e-55]} {Celegans: WBGene00022675, gbb-2, GABA B receptor subunit; GABAB2 receptor subunit, [Score=207, Expect=2e-57]} {Smed: dd_Smed_v6_51663_0_1, dd_Smed_v6_51663_0_1, [Score=151, Expect=1e-41]} {RNA1310_28849} {RNA815_36011} Mlig455_001517 {REF} {Length: 2539} {Pfam: 7 transmembrane sweet-taste receptor of 3 GCPR [PF00003.24, score=166.0]; Receptor family ligand binding region [PF01094.30, score=52.9]} {Human: ENSG00000136928, GABBR2, gamma-aminobutyric acid type B receptor subunit 2, [Score=236, Expect=1e-66]} {Mouse: ENSMUSG00000039809, Gabbr2, gamma-aminobutyric acid (GABA) B receptor, 2, [Score=236, Expect=1e-66]} {Dmel: FBgn0027575, GABA-B-R2, metabotropic GABA-B receptor subtype 2, [Score=220, Expect=6e-61]} {Celegans: WBGene00022675, gbb-2, GABA B receptor subunit; GABAB2 receptor subunit, [Score=228, Expect=2e-64]} {Smed: dd_Smed_v6_51663_0_1, dd_Smed_v6_51663_0_1, [Score=152, Expect=8e-42]} {RNA1310_28849} {RNA815_36011} |
| 84. | MligTC455_32644 | 41 | 0.86 | Mlig455_043770, Mlig455_043786 | Neo: - Age: - Region-enriched R2: 6.705/0.00336 |
1.808 | 0.983 | - | - | - | 0.825 | - | Mlig455_043770 {REF} {Length: 1011} {Pfam: PAN domain [PF00024.28, score=19.3]} {Smed: dd_Smed_v6_42798_0_1, dd_Smed_v6_42798_0_1, [Score=60.8, Expect=3e-11]} {RNA1509_35604} {RNA1310_57814} {RNA815_29718} Mlig455_043786 {REF} {Length: 1348} {Pfam: PAN domain [PF00024.28, score=19.3]} {RNA1509_35604} {RNA1310_34182} {RNA815_29718} |
|
| 85. | MligTC455_41106 | 42 | 0.88 | Mlig455_010275 | Neo: - Age: - Region-enriched R2: 5.386/0.03242 |
CALM1 | 1.806 | 0.808 | - | - | - | 0.998 | - | Mlig455_010275 {REF} {Length: 1557} {Pfam: EF hand [PF00036.34, score=32.5]; EF-hand domain pair [PF13499.8, score=30.4]; EF-hand domain [PF13405.8, score=29.3]} {Human: ENSG00000198668, CALM1, calmodulin 1, [Score=67.0, Expect=4e-14]; ENSG00000160014, CALM3, calmodulin 3, [Score=67.0, Expect=4e-14]; ENSG00000143933, CALM2, calmodulin 2, [Score=67.0, Expect=4e-14]} {Mouse: ENSMUSG00000019370, Calm3, calmodulin 3, [Score=67.0, Expect=3e-14]; ENSMUSG00000036438, Calm2, calmodulin 2, [Score=67.0, Expect=3e-14]; ENSMUSG00000001175, Calm1, calmodulin 1, [Score=67.0, Expect=3e-14]; ENSMUSG00000063130, Calml3, calmodulin-like 3, [Score=63.9, Expect=5e-13]} {Dmel: FBgn0000253, Cam, Calmodulin, [Score=66.2, Expect=4e-14]} {Celegans: WBGene00000552, cmd-1, Calmodulin, [Score=66.6, Expect=3e-14]} {Smed: dd_Smed_v6_255_0_1, dd_Smed_v6_255_0_1, [Score=66.6, Expect=2e-14]} {RNA1310_51265} |
| 86. | MligTC455_25921 | 329 | 6.86 | Mlig455_006703 | Neo: - Age: Down-Down-Down, logFC(26M/2M)=-2.996 Region-enriched R2: 6.614/0.00492 |
1.805 | 0.987 | - | - | - | 0.818 | - | Mlig455_006703 {REF} {Length: 664} {RNA1509_22927} {RNA1310_80445} {RNA815_41771.1} | |
| 87. | MligTC455_13030 | 30 | 0.63 | Mlig455_030520 | Neo: - Age: - |
1.802 | 0.814 | - | - | - | 0.988 | - | Mlig455_030520 {REF} {Length: 3950} {RNA1509_41925} {RNA1310_32300.1, RNA1509_41925} {RNA1509_41925, RNA815_29217} | |
| 88. | MligTC455_46022 | 51 | 1.07 | Mlig455_009838 | Neo: - Age: - |
1.801 | 0.815 | - | - | - | 0.986 | - | Mlig455_009838 {REF} {Length: 1632} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=54.1]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=20.2]} {Dmel: FBgn0038874, ETHR, [Score=50.1, Expect=2e-06]} {Smed: dd_Smed_v6_17171_0_1, dd_Smed_v6_17171_0_1, [Score=175, Expect=2e-51]} {RNA1310_62858} {RNA815_33606} | |
| 89. | MligTC455_43964 | 422 | 8.8 | Mlig455_003555, Mlig455_015506 | Neo: - Age: logFC(26M/2M)=0.500 Region-specific R2: 3.721 Region-enriched R2: 4.796/0.00000 Regeneration-downregulated R2: -1.526 Regeneration-depleted R2: -1.526 |
1.798 | 0.832 | - | - | - | 0.966 | - | Mlig455_003555 {REF} {Length: 745} {RNA1509_44220} {RNA1310_56516, RNA1509_44220} {RNA1509_44220, RNA815_28877} Mlig455_015506 {REF} {Length: 752} {RNA1509_44220} {RNA1310_56516} {RNA815_28877} |
|
| 90. | MligTC455_31163 | 72 | 1.51 | Mlig455_045625 | Neo: - Age: Up-Down-Down |
1.795 | 0.962 | - | - | - | 0.833 | - | Mlig455_045625 {REF} {Length: 1957} {RNA1509_21720} {RNA1310_14760, RNA1509_21720} {RNA1509_21720, RNA815_24583} | |
| 91. | MligTC455_38949 | 105 | 2.19 | Mlig455_065209 | Neo: - Age: - Region-specific R2: 7.633 Region-enriched R2: 10.088/0.00000 |
1.793 | 0.987 | - | - | - | 0.806 | - | Mlig455_065209 {REF} {Length: 591} {Pfam: Insulin/IGF/Relaxin family [PF00049.20, score=23.2]} {RNA1509_44618} {RNA1310_63839, RNA1509_44618} {RNA1509_44618, RNA815_35329} | |
| 92. | MligTC455_17479 | 32 | 0.66 | Mlig455_032081, Mlig455_070278 | Neo: - Age: logFC(26M/2M)=-0.516 |
CHRNA3 | 1.786 | 0.952 | - | - | - | 0.834 | - | Mlig455_032081 {REF} {Length: 2787} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=230.7]; Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=221.4]} {Human: ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=368, Expect=1e-121]; ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=366, Expect=5e-121]} {Mouse: ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=378, Expect=6e-126]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=361, Expect=3e-119]} {Dmel: FBgn0266347, nAChRalpha4, nicotinic Acetylcholine Receptor alpha4, [Score=461, Expect=3e-158]} {Celegans: WBGene00006797, unc-63, Acetylcholine receptor subunit alpha-type unc-63, [Score=381, Expect=3e-127]} {Smed: dd_Smed_v6_9799_0_1, dd_Smed_v6_9799_0_1, [Score=614, Expect=0.0]} {RNA1509_28642} {RNA1310_34709} {RNA815_44960} Mlig455_070278 {REF} {Length: 2270} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=232.1]; Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=221.2]} {Human: ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=369, Expect=7e-122]; ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=366, Expect=4e-121]} {Mouse: ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=378, Expect=9e-126]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=362, Expect=1e-119]} {Dmel: FBgn0266347, nAChRalpha4, nicotinic Acetylcholine Receptor alpha4, [Score=461, Expect=3e-158]} {Celegans: WBGene00006797, unc-63, Acetylcholine receptor subunit alpha-type unc-63, [Score=382, Expect=2e-127]} {Smed: dd_Smed_v6_9799_0_1, dd_Smed_v6_9799_0_1, [Score=616, Expect=0.0]} {RNA1509_16247} {RNA1310_34709} {RNA815_44960} |
| 93. | MligTC455_39632 | 71 | 1.48 | Mlig455_039338 | Neo: - Age: Up-Down-Down Region-enriched R2: 4.404/0.02299 |
APBA1 | 1.784 | 0.815 | - | - | - | 0.969 | - | Mlig455_039338 {REF} {Length: 5781} {Pfam: Phosphotyrosine interaction domain (PTB/PID) [PF00640.25, score=122.8]; PDZ domain [PF00595.26, score=87.0]; PDZ domain [PF17820.3, score=50.7]} {Human: ENSG00000107282, APBA1, amyloid beta precursor protein binding family A member 1, [RH, Score=476, Expect=5e-157]; ENSG00000276497, APBA1, amyloid beta precursor protein binding family A member 1, [RH, Score=474, Expect=2e-161]; ENSG00000276495, APBA2, amyloid beta precursor protein binding family A member 2, [RH, Score=474, Expect=3e-157]; ENSG00000034053, APBA2, amyloid beta precursor protein binding family A member 2, [RH, Score=474, Expect=3e-157]} {Mouse: ENSMUSG00000030519, Apba2, amyloid beta (A4) precursor protein-binding, family A, member 2, [RH, Score=476, Expect=3e-158]; ENSMUSG00000024897, Apba1, amyloid beta (A4) precursor protein binding, family A, member 1, [RH, Score=475, Expect=2e-156]} {Dmel: FBgn0052677, X11Lbeta, [Score=532, Expect=2e-168]} {Celegans: WBGene00002999, lin-10, [Score=519, Expect=1e-172]} {Smed: dd_Smed_v6_2836_0_2, dd_Smed_v6_2836_0_2, [Score=550, Expect=0.0]} {RNA1509_43941, RNA1509_55204} {RNA1310_18864.1, RNA1509_43941} {RNA1509_43941, RNA815_11653} |
| 94. | MligTC455_13963 | 31 | 0.64 | Mlig455_052027 | Neo: - Age: Down-Up-Down |
1.78 | 0.988 | - | - | - | 0.792 | - | Mlig455_052027 {REF} {Length: 1717} {RNA1509_48973} {RNA1310_34931} {RNA815_59614} | |
| 95. | MligTC455_41988 | 81 | 1.68 | Mlig455_049279, Mlig455_050624 | Neo: - Age: - |
1.779 | 0.823 | - | - | - | 0.956 | - | Mlig455_049279 {REF} {Length: 6361} {Pfam: Innexin [PF00876.20, score=408.1]} {Dmel: FBgn0085387, shakB, shaking B, [RH, Score=133, Expect=1e-34]} {Celegans: WBGene00002123, inx-1, Innexin, [Score=341, Expect=5e-114]} {Smed: dd_Smed_v6_11077_0_2, dd_Smed_v6_11077_0_2, [RH, Score=483, Expect=3e-168]} {RNA1509_51082} {RNA1310_22380} {RNA815_25566} Mlig455_050624 {REF} {Length: 2845} {Pfam: Innexin [PF00876.20, score=408.0]} {Dmel: FBgn0085387, shakB, shaking B, [RH, Score=133, Expect=2e-34]} {Celegans: WBGene00002123, inx-1, Innexin, [Score=342, Expect=3e-114]} {Smed: dd_Smed_v6_11077_0_2, dd_Smed_v6_11077_0_2, [RH, Score=484, Expect=1e-168]} {RNA1509_51082} {RNA1310_22380} {RNA815_1848.2} |
|
| 96. | MligTC455_22323 | 68 | 1.42 | Mlig455_000713, Mlig455_000766 | Neo: - Age: - |
HCN4 | 1.777 | 0.821 | - | - | - | 0.956 | - | Mlig455_000713 {REF} {Length: 3555} {Pfam: Ion transport protein N-terminal [PF08412.12, score=83.6]; Cyclic nucleotide-binding domain [PF00027.31, score=70.8]; Ion transport protein [PF00520.33, score=62.7]} {Human: ENSG00000138622, HCN4, hyperpolarization activated cyclic nucleotide gated potassium channel 4, [Score=581, Expect=0.0]; ENSG00000099822, HCN2, hyperpolarization activated cyclic nucleotide gated potassium and sodium channel 2, [Score=568, Expect=0.0]} {Mouse: ENSMUSG00000032338, Hcn4, hyperpolarization-activated, cyclic nucleotide-gated K+ 4, [Score=579, Expect=0.0]; ENSMUSG00000020331, Hcn2, hyperpolarization-activated, cyclic nucleotide-gated K+ 2, [Score=563, Expect=0.0]} {Dmel: FBgn0263397, Ih, I[[h]] channel, [RH, Score=512, Expect=1e-161]} {Celegans: WBGene00006526, tax-4, Cyclic nucleotide-gated cation channel, [Score=133, Expect=8e-32]} {Smed: dd_Smed_v6_16523_0_1, dd_Smed_v6_16523_0_1, [Score=859, Expect=0.0]} {RNA1509_59211} {RNA1310_33761} {RNA815_15561.1} Mlig455_000766 {REF} {Length: 4037} {Pfam: Ion transport protein N-terminal [PF08412.12, score=83.5]; Cyclic nucleotide-binding domain [PF00027.31, score=70.7]; Ion transport protein [PF00520.33, score=62.6]} {Human: ENSG00000138622, HCN4, hyperpolarization activated cyclic nucleotide gated potassium channel 4, [Score=566, Expect=0.0]; ENSG00000099822, HCN2, hyperpolarization activated cyclic nucleotide gated potassium and sodium channel 2, [Score=553, Expect=0.0]} {Mouse: ENSMUSG00000032338, Hcn4, hyperpolarization-activated, cyclic nucleotide-gated K+ 4, [Score=564, Expect=0.0]; ENSMUSG00000020331, Hcn2, hyperpolarization-activated, cyclic nucleotide-gated K+ 2, [Score=548, Expect=3e-180]} {Dmel: FBgn0263397, Ih, I[[h]] channel, [Score=502, Expect=4e-166]} {Celegans: WBGene00006526, tax-4, Cyclic nucleotide-gated cation channel, [Score=133, Expect=8e-32]} {Smed: dd_Smed_v6_16523_0_1, dd_Smed_v6_16523_0_1, [Score=844, Expect=0.0]} {RNA1509_59211} {RNA1310_33761} {RNA815_15561.1} |
| 97. | MligTC455_41512 | 268 | 5.59 | Mlig455_057018 | Neo: - Age: Down-Down-Up |
HMCN2 | 1.773 | - | - | 0.811 | - | 0.962 | - | Mlig455_057018 {REF} {Length: 2115} {Pfam: Immunoglobulin I-set domain [PF07679.18, score=167.2]; Immunoglobulin domain [PF13927.8, score=124.8]; Immunoglobulin domain [PF13895.8, score=78.7]; Immunoglobulin domain [PF00047.27, score=77.2]; Immunoglobulin V-set domain [PF07686.19, score=45.1]; CD80-like C2-set immunoglobulin domain [PF08205.14, score=40.4]} {Human: ENSG00000148357, HMCN2, hemicentin 2, [Score=83.6, Expect=3e-16]; ENSG00000138347, MYPN, myopalladin, [Score=82.8, Expect=4e-16]; ENSG00000129116, PALLD, palladin, cytoskeletal associated protein, [Score=82.4, Expect=4e-16]; ENSG00000072195, SPEG, SPEG complex locus, [Score=82.0, Expect=6e-16]} {Mouse: ENSMUSG00000061462, Obscn, obscurin, cytoskeletal calmodulin and titin-interacting RhoGEF, [Score=84.7, Expect=8e-17]; ENSMUSG00000058056, Palld, palladin, cytoskeletal associated protein, [Score=81.6, Expect=4e-16]; ENSMUSG00000026207, Speg, SPEG complex locus, [Score=80.9, Expect=9e-16]} {Dmel: FBgn0052311, zormin, [Score=102, Expect=7e-23]} {Celegans: WBGene00006820, unc-89, Muscle M-line assembly protein unc-89, [Score=77.4, Expect=8e-15]} {Smed: dd_Smed_v6_13910_0_1, dd_Smed_v6_13910_0_1, [Score=127, Expect=3e-31]} {RNA1509_44395} {RNA1310_15128.1, RNA1509_44395} {RNA1509_44395, RNA815_29263} |
| 98. | MligTC455_20200 | 47 | 0.97 | Mlig455_021962 | Neo: - Age: - |
KCNMA1 | 1.768 | 0.804 | - | - | - | 0.964 | - | Mlig455_021962 {REF} {Length: 3749} {Pfam: Calcium-activated BK potassium channel alpha subunit [PF03493.20, score=76.1]; Ion channel [PF07885.18, score=61.3]; Ion transport protein [PF00520.33, score=34.6]; Ligand-gated ion channel [PF00060.28, score=23.9]} {Human: ENSG00000156113, KCNMA1, potassium calcium-activated channel subfamily M alpha 1, [Score=634, Expect=0.0]} {Mouse: ENSMUSG00000063142, Kcnma1, potassium large conductance calcium-activated channel, subfamily M, alpha member 1, [Score=628, Expect=0.0]} {Dmel: FBgn0003429, slo, slowpoke, [Score=449, Expect=8e-139]} {Celegans: WBGene00004830, slo-1, Calcium-activated potassium channel slo-1, [Score=444, Expect=2e-137]} {Smed: dd_Smed_v6_5509_0_1, dd_Smed_v6_5509_0_1, [Score=610, Expect=0.0]} {RNA1310_43306.1} {RNA815_38585} |
| 99. | MligTC455_42520 | 221 | 4.6 | Mlig455_051277 | Neo: - Age: Down-Up-Up Region-specific R2: 7.331 Region-enriched R2: 7.171/0.00000 Regeneration-downregulated R2: -3.384 Regeneration-depleted R2: -3.384 |
1.768 | 0.988 | - | - | - | 0.780 | - | Mlig455_051277 {REF} {Length: 969} {RNA1310_42329} {RNA815_20649} | |
| 100. | MligTC455_22403 | 76 | 1.58 | Mlig455_043840, Mlig455_047410 | Neo: - Age: - |
1.763 | 0.811 | - | - | - | 0.952 | - | Mlig455_043840 {REF} {Length: 1721} {Pfam: Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=18.2]} {Smed: dd_Smed_v6_43697_0_1, dd_Smed_v6_43697_0_1, [Score=84.3, Expect=4e-19]} {RNA1310_93309} {RNA815_54296} Mlig455_047410 {REF} {Length: 1771} {Pfam: Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=18.6]} {Smed: dd_Smed_v6_43697_0_1, dd_Smed_v6_43697_0_1, [Score=84.3, Expect=4e-19]} {RNA1310_96760.2} {RNA815_54296} |
There are 430 more genes with r >= 0.95